Neuromyelitis Optica Spectrum Disorder – Intelligence Pharma

Alexion bets $1.4B on Portola and its laggard bleeding drug Andexxa

08/05/2020 by Thanasis Chalikias, posted in News

Alexion bets $1.4B on Portola and its laggard bleeding drug Andexxa

10 Takeover Targets to Watch This Fall

19/09/201918/09/2019 by Thanasis Chalikias, posted in Έρευνες/Κλινικές Μελέτες, Επιστημονικά Νέα, Marketing/Managment, News

10 Takeover Targets to Watch This Fall

Alexion eyes $500M-plus in new Soliris sales with latest rare-disease win

25/09/201824/09/2018 by Thanasis Chalikias, posted in Έρευνες/Κλινικές Μελέτες, Επιστημονικά Νέα, Marketing/Managment, News

Alexion eyes $500M-plus in new Soliris sales with latest rare-disease win

Design a site like this with WordPress.com